Cyclo Therapeutics Inc (CYTH)
1.25
-0.03
(-2.34%)
USD |
NASDAQ |
Jun 03, 16:00
1.25
0.00 (0.00%)
After-Hours: 20:00
Cyclo Therapeutics Price to Book Value: 58.64 for June 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 60.04 |
| May 30, 2024 | 60.98 |
| May 29, 2024 | 60.51 |
| May 28, 2024 | 60.04 |
| May 24, 2024 | 63.33 |
| May 23, 2024 | 60.98 |
| May 22, 2024 | 60.51 |
| May 21, 2024 | 63.80 |
| May 20, 2024 | 66.61 |
| May 17, 2024 | 65.67 |
| May 16, 2024 | 64.27 |
| May 15, 2024 | 67.08 |
| May 14, 2024 | 66.14 |
| May 13, 2024 | 65.67 |
| May 10, 2024 | 68.96 |
| May 09, 2024 | 68.02 |
| May 08, 2024 | 70.36 |
| May 07, 2024 | 70.83 |
| May 06, 2024 | 71.77 |
| May 03, 2024 | 70.83 |
| May 02, 2024 | 68.95 |
| May 01, 2024 | 68.02 |
| April 30, 2024 | 68.49 |
| April 29, 2024 | 68.95 |
| April 26, 2024 | 59.10 |
| Date | Value |
|---|---|
| April 25, 2024 | 60.51 |
| April 24, 2024 | 60.98 |
| April 23, 2024 | 56.76 |
| April 22, 2024 | 59.10 |
| April 19, 2024 | 54.41 |
| April 18, 2024 | 56.29 |
| April 17, 2024 | 56.76 |
| April 16, 2024 | 57.23 |
| April 15, 2024 | 58.17 |
| April 12, 2024 | 59.10 |
| April 11, 2024 | 64.26 |
| April 10, 2024 | 65.20 |
| April 09, 2024 | 66.61 |
| April 08, 2024 | 66.14 |
| April 05, 2024 | 62.39 |
| April 04, 2024 | 64.26 |
| April 03, 2024 | 63.79 |
| April 02, 2024 | 68.49 |
| April 01, 2024 | 63.79 |
| March 31, 2024 | |
| March 28, 2024 | 8.391 |
| March 27, 2024 | 8.451 |
| March 26, 2024 | 8.451 |
| March 25, 2024 | 8.632 |
| March 22, 2024 | 8.994 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.277
Minimum
May 20 2022
71.77
Maximum
May 06 2024
10.10
Average
4.806
Median
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | 19.01 |
| iBio Inc | 0.8186 |
| Theriva Biologics Inc | 0.1431 |
| Oragenics Inc | 8.809 |
Price to Book Value Related Metrics
| PS Ratio | 22.46 |
| Price | 1.25 |
| Earnings Yield | -80.00% |
| Market Cap | 35.77M |